Molecular Components of Wnt/β-catenin Pathway As Therapeutic Targets For Upper Gastrointestinal Cancers

Publisher： Bentham Science Publishers

ISSN： 2212-697X

Source： Clinical Cancer Drugs, Vol.2, Iss.2, 2015-10, pp. : 72-79

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

A Wnt-ow of Opportunity: Targeting the Wnt/&bgr;-Catenin Pathway in Breast Cancer

By  

Current Drug Targets, Vol. 11, Iss. 9, 2010-09 ,pp. : 1074-1088

Bentham Science Publishers

Access to resources Recommend Favorite

Wnt / &bgr;-Catenin Signaling Pathway as Novel Cancer Drug Targets

By  

Current Cancer Drug Targets, Vol. 4, Iss. 8, 2004-12 ,pp. : 653-671

Bentham Science Publishers

Access to resources Recommend Favorite

Increase Signaling of Wnt/β-Catenin Pathway and Presence of Apoptosis in Cerebellum of Kindled Rats

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 16, Iss. 7, 2017-10 ,pp. : 772-780

Bentham Science Publishers

Access to resources Recommend Favorite

The potential of targeting Wnt/β-catenin in colon cancer

By Sebio Ana   Kahn Michael   Lenz Heinz-Josef  

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 6, 2014-06 ,pp. : 611-615

Informa Healthcare

Access to resources Recommend Favorite

Endocytic Trafficking and Wnt/&bgr;-Catenin Signaling

By  

Current Drug Targets, Vol. 12, Iss. 8, 2011-07 ,pp. : 1216-1222

Bentham Science Publishers

Access to resources Recommend Favorite